Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials

Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials

SINGAPORE, Oct. 27, 2025 /PRNewswire/ -- Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant...

menu
menu